Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Показать другие версии (1)

BACKGROUND: Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) in terms of reducing the risk of joint damage, improving physical function and improving quality of life. This Cochrane review is an update of a review of the treatment of RA with...

Полное описание

Библиографические подробности
Главные авторы:	Ruiz Garcia, V, Jobanputra, P, Burls, A, Cabello, J, Vela Casasempere, P, Bort-Marti, S, Kynaston-Pearson, F
Формат:	Journal article
Язык:	English
Опубликовано:	2014

Схожие документы

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
по: Ruiz Garcia, V, и др.
Опубликовано: (2011)

Certolizumab pegol in therapy for rheumatoid arthritis
по: Galina Viktorovna Lukina, и др.
Опубликовано: (2012-06-01)

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
по: M Connock, и др.
Опубликовано: (2010-10-01)

QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
по: Vera Nikolayevna Amirdjanova, и др.
Опубликовано: (2012-10-01)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
по: Evgeniy L'vovich Nasonov, и др.
Опубликовано: (2011-02-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
по: Emna Hannech, и др.
Опубликовано: (2021-06-01)

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
по: Dmitry Evgenyevich Karateev, и др.
Опубликовано: (2012-04-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
по: T. V. Korotaeva, и др.
Опубликовано: (2015-10-01)

Certolizumab pegol – new option in the treatment of psoriatic arthritis
по: Maria Majdan, и др.
Опубликовано: (2014-07-01)

Certolizumab pegol in the treatment of spondyloarthritis
по: Mariusz Korkosz
Опубликовано: (2014-09-01)

Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
по: Smolen, JS, и др.
Опубликовано: (2024)

COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
по: Purcaru, O, и др.
Опубликовано: (2010)

Prefilled certolizumab pegol (Cimzia&reg;) syringes for self-use in the treatment of rheumatoid arthritis
по: J Rosa, и др.
Опубликовано: (2010-08-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
по: Sh. F. Erdes
Опубликовано: (2016-02-01)

Eosinophilic Annular Erythema Due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine
по: Andrea Bassi, и др.
Опубликовано: (2023-04-01)

The efficacy of certolizumab pegol in rheumatoid arthritis assessed by gray scale and power Doppler ultrasonography: case reports
по: José Alexandre Mendonça, и др.
Опубликовано: (2019-02-01)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
по: Stéphane Paul, и др.
Опубликовано: (2020-07-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
по: Mehmet Baysal, и др.
Опубликовано: (2018-09-01)

Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
по: Lindsey J. Wanberg, и др.
Опубликовано: (2024-06-01)

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
по: Tanaka, Y, и др.
Опубликовано: (2023)

Experience with long-term use of certolizumab pegol (Cimzia)
по: Karine Arnoldovna Lytkina, и др.
Опубликовано: (2013-10-01)

Experience with long-term use of certolizumab pegol (Cimzia)
по: Karine Arnoldovna Lytkina, и др.
Опубликовано: (2013-10-01)

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
по: Ian R White, и др.
Опубликовано: (2022-01-01)

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population
по: Ian R. White, и др.
Опубликовано: (2022-01-01)

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
по: Vivian P. Bykerk, и др.
Опубликовано: (2023-02-01)

Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study
по: Glatt, S, и др.
Опубликовано: (2019)

Quantitation of certolizumab pegol by validated liquid chromatography methods
по: Clóvis Dervil Appratto Cardoso Júnior, и др.
Опубликовано: (2023-11-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
по: I.L. Khalif, и др.
Опубликовано: (2018-04-01)

Active axial spondyloarthritis: potential role of certolizumab pegol
по: Ranatunga S, и др.
Опубликовано: (2014-02-01)

Certolizumab pegol w leczeniu reumatoidalnego zapalenia stawów
по: Piotr Wiland, и др.
Опубликовано: (2011-08-01)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
по: Acosta-Felquer ML, и др.
Опубликовано: (2016-03-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
по: P. I. Novikov, и др.
Опубликовано: (2018-07-01)

Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.
по: Hazes, J, и др.
Опубликовано: (2010)

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
по: A. Spadaro, и др.
Опубликовано: (2013-07-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
по: Wojciech Blonski, и др.
Опубликовано: (2012-04-01)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
по: O V Knyazev, и др.
Опубликовано: (2018-06-01)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
по: Yael Sharon, и др.
Опубликовано: (2020-06-01)

Possible relationship between certolizumab pegol and arrhythmias: report of two cases
по: R. Talotta, и др.
Опубликовано: (2016-09-01)

Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors
по: Syuichi Koarada, и др.
Опубликовано: (2015-01-01)

Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
по: Jeffrey R. Curtis, и др.
Опубликовано: (2017-12-01)